CVS Health’s (CVS) “Neutral” Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald reissued their neutral rating on shares of CVS Health (NYSE:CVS – Free Report) in a research report report published on Tuesday morning, Benzinga reports. The brokerage currently has a $58.00 price objective on the pharmacy operator’s stock. Several other research firms have also recently weighed in on CVS. Wells Fargo & Company dropped […]

Leave a Reply

Your email address will not be published.

Previous post DAO Maker Price Tops $0.45 (DAO)
Next post Will there be a Kamala Harris v. Donald Trump debate? Here’s what we know